{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:26:39Z","timestamp":1790227599126,"version":"4.1.0"},"reference-count":49,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T00:00:00Z","timestamp":1514937600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesia"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Adverse drug reactions are a cause of significant morbidity and mortality to patients and a source of financial burden to the healthcare system. Of the wide spectrum of adverse drug reactions, the most concerning to the anaesthetist remain anaphylaxis and malignant hyperthermia. Although the incidence of anaphylaxis under anaesthesia is difficult to ascertain, it occurs commonly enough that most anaesthetists will manage at least one case in their career. The wide range of drugs given in the peri\u2010operative period and the variable presentation in the anaesthetised patient can delay diagnosis and treatment, and adversely affect outcome. Furthermore, despite improvements in testing, causative drugs can still be difficult to identify, as adverse reactions may be mediated by mechanisms other than IgE activation. With an increase in the reporting of anaphylaxis to newer anaesthetic drugs such as sugammadex, combined with change over the recent decades in the most likely causative peri\u2010operative agents, it is imperative anaesthetists remain up to date on recent developments. In addition, they should be vigilant to patient characteristics, including pharmacogenetic variations that may predispose to adverse drug reactions, in order to help minimise risks of a reaction. The severity of adverse drug reactions to peri\u2010operative drugs means morbidity and mortality remain high.<\/jats:p>","DOI":"10.1111\/anae.14143","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T14:56:55Z","timestamp":1515769015000},"page":"76-84","source":"Crossref","is-referenced-by-count":104,"title":["Adverse drug reactions"],"prefix":"10.1111","volume":"73","author":[{"given":"K.","family":"Patton","sequence":"first","affiliation":[{"name":"Department of Anaesthesia University Hospital Bristol Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Borshoff","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia and Pain Medicine St. John of God Murdoch Hospital Perth Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,1,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40521-016-0078-0"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2007.01489.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1261"},{"key":"e_1_2_10_6_1","first-page":"42","article-title":"NAP6 Anaphylaxis; what and why?","volume":"82","author":"Cook T","year":"2013","journal-title":"Royal College of Anaesthetists Bulletin"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12826"},{"key":"e_1_2_10_8_1","article-title":"Airway Complications","author":"Cook TM","year":"2018","journal-title":"Anaesthesia"},{"key":"e_1_2_10_9_1","first-page":"1","volume-title":"International drug monitoring: role of national centres","author":"World Health Organisation","year":"1972"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7425.1222"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2001.00002.x-i1"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjaceaccp\/mkt034"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12632"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/11631760-000000000-00000"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpaic.2011.04.010"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2006.03.002"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200309000-00007"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2008.05733.x"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2015.11.002"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3181d7e31c"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12290"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.13081"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12736"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.02.023"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12277"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmhg.2013.03.003"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2015.11.001"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2009.03404.x"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2007.01313.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(06)80017-5"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.13273"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2011.06809.x"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12003"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02248.x"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1103900221"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12617"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2009.06177_1.x"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2011.06995.x"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1404200116"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.13178"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/psb.1383"},{"key":"e_1_2_10_43_1","unstructured":"Medicines and Healthcare products Regulatory Agency.The Yellow Card Scheme: guidance for health professionals [Internet]. UK; Medicines and Healthcare products Regulatory Agency.2015[updated Jan 2017].https:\/\/www.gov.uk\/guidance\/the-yellow-card-scheme-guidance-for-healthcare-professionals(accessed 01\/03\/2017)."},{"key":"e_1_2_10_44_1","unstructured":"Uppsala Monitoring Centre website.https:\/\/www.who-umc.org(accessed 10\/03\/2017)."},{"key":"e_1_2_10_45_1","unstructured":"Malignant Hyperthermia Unit.http:\/\/www.leedsth.nhs.uk\/a-z-of-services\/malignant-hyperthermia\/(accessed 12\/03\/2017)."},{"key":"e_1_2_10_46_1","first-page":"442","article-title":"Reducing the risk of anaphylaxis during anaesthesia: 2011 updated guidelines for clinical practice","volume":"21","author":"Mertes PM","year":"2011","journal-title":"Journal of Investigational Allergology and Clinical Immunology"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2006.05.010"},{"key":"e_1_2_10_48_1","volume-title":"Drug allergy: diagnosis and management of drug allergy in adults, children and young people","author":"National Institute for Health and Care Excellence","year":"2014"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12926"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12142"}],"container-title":["Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fanae.14143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/anae.14143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T19:52:45Z","timestamp":1761681165000},"score":1,"resource":{"primary":{"URL":"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/10.1111\/anae.14143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":49,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1111\/anae.14143"],"URL":"https:\/\/doi.org\/10.1111\/anae.14143","archive":["Portico"],"relation":{},"ISSN":["0003-2409","1365-2044"],"issn-type":[{"value":"0003-2409","type":"print"},{"value":"1365-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}